Optimal Systemic Therapy In The Setting Of Hepatic Thomas Powles, M.d., Mbbs, Mrcp

Optimal Systemic Therapy in the Setting of Hepatic Thomas Powles, M.D., MBBS, MRCP

Renal Cell Carcinoma | Thomas Powles, MBBS, MRCP, MD

Research To Practice

Thomas Powles, MD, MBBS, MRCP, regarding immunotherapy & chemotherapy combinations in bladder cancer

Detection of Bone Disease Thomas Powles, M.D.

Urothelial Bladder Cancer | Thomas Powles, MBBS, MRCP, MD

Research To Practice

Thomas Powles, MD, MBBS, MRCP, on the evolving landscape of metastatic bladder cancer

Dr. Powles on the Mission of the Uromigos Twitter Group

Thomas Powles, MD, MBBS, MRCP, considers molecular markers and muscle-invasive bladder cancer

Dr. Powles on Monitoring Immunotherapy Effects in Patients with RCC

Tumar Heterogeneity Barrier to Therapy - Prof. Tom Powles

EMJ

Emerging immunotherapies for kidney cancer

EMJ

Examining the State of the Science on New Therapies in Bladder Cancer

PeerView Oncology

TTP: Based on Davidson's Principle's and Practice of Medicine 24th Edition | Atlas of Medicine

Atlas of Medicine

Systemic Therapy with Dr. Bernie Eigl

ProstateCancerCanada

Advanced/Metastatic Urothelial Carcinoma: Understanding Novel Immunotherapy Maintenance Strategies

PeerView Oncology

The Workup

THANC Foundation

#LWKC Webinar - Advancements in Metastatic Kidney Cancer with Professor Thomas Powles

Kidney Cancer UK

Clinical Pearls: Managing Chronic Illness

Institute for Neuro-Immune Medicine

Management of ET